RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR TREATMENT IMPROVES MACROPHAGE SUPPRESSION OF GRANULOCYTE AND MACROPHAGE GROWTH AFTER BURN AND BURN WOUND-INFECTION
Rl. Gamelli et al., RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR TREATMENT IMPROVES MACROPHAGE SUPPRESSION OF GRANULOCYTE AND MACROPHAGE GROWTH AFTER BURN AND BURN WOUND-INFECTION, The journal of trauma, injury, infection, and critical care, 39(6), 1995, pp. 1141-1147
Granulocyte and macrophage production after burn injury or burn wound
infection is significantly reduced and further compromised by endotoxi
n (ET), Moreover, the macrophage seems to be the major source of this
hone marrow suppression, We sought to determine if recombinant human g
ranulocyte colony-stimulating factor (rhG-CSF), a hematopoietic growth
factor that is capable of improving survival after experimental burn
wound sepsis, altered postburn macrophage-mediated marrow suppression,
Groups of male BDF1 mice (n = 6 to 10) receiving a 15% total body sur
face area burn +/- infection (B or B + I) with Pseudomonas aeruginosa
were injected with 100 ng rhG-CSF twice daily. On day 3, peritoneal-el
icited macrophages (5 x 10(6) cells/mL) from either rhG-CSF-treated or
control(5% dextrose in water) mice were incubated +/- ET (300 ng/mL).
The resultant macrophage supernatant was added to cultures of target
marrow granulocyte-macrophage progenitor cells (GM-CFC) at a volume of
1:10. The GM-CFC growth as a percentage of cultures not containing ma
crophage supernatant were compared and reductions in the number of GM-
CFC taken as an index of marrow suppression, Macrophages obtained from
B and B + I animals reduced target GM-CFC growth, compared with macro
phages from normal animals (B vs, normal animals p < 0.05). In additio
n, ET-stimulated macrophages induced further bone marrow suppression f
or all three groups (p < 0.01). Macrophages from granulocyte colony-st
imulating factor-treated animals caused significantly less bone marrow
suppression, compared with untreated animals for all groups (p < 0.05
to 0.01). Granulocyte colony-stimulating factor administration postbu
rn, in addition to serving as a direct bone marrow stimulant, also alt
ers the macrophage secretory profile and ameliorates macrophage-induce
d bone marrow suppression.